Micron expects fiscal Q1 revenue of $61.5B ±$1.5B as it raises fiscal 2027 CapEx plans amid tighter 2027-2028 supply-demand (NASDAQ:MU)October 1, 2026
Mizuho cuts BioXcel to neutral, cites reduced expectations for lead drug (BTAI) Markets August 16, 2023 juststock Mizuho downgraded BioXcel Therapeutics (NASDAQ:BTAI) to impartial and slashed its worth goal within the wake of the corporate’s Q2…
